Blood cancer Clinical Trials in Memphis, TN
As of August 2026, 43 paid clinical trials are recruiting for Blood cancer in Memphis, Tennessee. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
43 clinical trials for Blood cancer
·Clear filters·SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Project: Every Child for Younger Patients With Cancer
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Familial Investigations of Childhood Cancer Predisposition
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
Response to Influenza Vaccination in Pediatric Oncology Patients
Investigation of the Genetics of Hematologic Diseases
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Top Research Study Locations in Memphis
Researchers run research studies in Memphis, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| St. Jude Children's Research Hospital | Sickle Cell Disease, Acute Lymphoblastic Leukemia, Hematologic Malignancy | 126 |
| Baptist Memorial Hospital and Cancer Center-Memphis | Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 51 |
| Saint Jude Children's Research Hospital | Malignant Solid Neoplasm, Neuroblastoma, Acute Myeloid Leukemia Post Cytotoxic Therapy | 26 |
| Le Bonheur Children's Hospital | Congenital Heart Disease (CHD), Alagille Syndrome, Anti-myostatin | 21 |
| Baptist Cancer Center | Non-Small Cell Lung Cancer, Breast Cancer, Chronic Graft-versus-host-disease | 12 |
| Baptist Clinical Research Institute | Non-small Cell Lung Cancer, Acute Myeloid Leukemia (AML), Acute Myocardial Infarction | 9 |
| University of Tennessee Health Science Center | Aneurysm, Brain, Buccal Mucosa Squamous Cell Carcinoma, Cancer | 9 |
| Regional One Health | Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Burn, Cesarean Delivery | 8 |
| Baptist Memorial Hospital | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 7 |
| LeBonheur Children's Hospital | Anesthesia, Children, Congenital Abnormalities | 6 |
| Southern College of Optometry | Amblyopia, Choroid, Intermittent Exotropia | 6 |
| Baptist Memorial Hospital for Women | Malignant Solid Neoplasm, Breast Carcinoma, Cancer | 5 |
| Clinical Neuroscience Solutions, Inc. | Major Depressive Disorder, Attention-Deficit/Hyperactivity Disorder, Chronic Migraine | 5 |
| Memphis VA Medical Center, Memphis, TN | Atherosclerosis, Chronic Kidney Disease (CKD) Stage 5, Dialysis Dependency | 4 |
| St Jude Children's Research Hospital | AML/MDS, Anesthesia, B-ALL | 4 |
| The Southern College of Optometry | Dry Eye, Presbyopia, Contact Lens Comfort | 4 |
| CNS Healthcare - Memphis | Diabetic Peripheral Neuropathic Pain, Obstructive Sleep Apnea (OSA), Proteinuric Kidney Disease | 3 |
| LifeDoc Health | Diabetes Mellitus, Type 2, Obesity, Overweight | 3 |
| Methodist Le Bonheur Healthcare | Coronary Artery Disease, Spinal Muscular Atrophy (SMA) | 3 |
| Methodist University Hospital | Intracerebral Hemorrhage, Ischemic Stroke, Atrial Fibrillation | 3 |
| Semmes Murphey Clinic | ICAD - Intracranial Atherosclerotic Disease, Intracranial Aneurysms, Ischemic Stroke | 3 |
| Baptist Cancer Center - Memphis | Colorectal Cancer, Esophageal Adenocarcinoma, Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 2 |
| CNS Healthcare | Diabetes Mellitus, Type 2, Obesity, Type 2 Diabetes | 2 |
| Clinical Neuroscience Solutions Inc. | Atopic Dermatitis, Clostridoides Difficile Associated Disease | 2 |
| Clinical Neuroscience Solutions, Inc - Memphis | Chronic Idiopathic Constipation (CIC), Chronic Migraine, Episodic Migraine | 2 |
Active & Upcoming Studies in Memphis (2026)
Recruiting trials in Memphis grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (170 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Cardiovascular (25 active studies)
- PRecision Integrated Saturation Monitor · Le Bonheur Children's Hospital
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
Neurology & pain (22 active studies)
- Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures · Phase 4 · Azurity Pharmaceuticals
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. · Phase 2 · Incannex Healthcare Ltd
Diabetes & metabolic (18 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Pediatric (16 active studies)
- Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma · St. Jude Children's Research Hospital
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · Phase 1 · St. Jude Children's Research Hospital
HIV / STI (11 active studies)
- Combatting HIV Or Other STIs Early (CHOOSE) · Phase 2 · Westat
- Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Mental health & behavior (7 active studies)
- A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults · Phase 3 · Axsome Therapeutics, Inc.
- Feasibility of Incorporating a Standardized Substance Use Measure With Linked-Brief Intervention Into Routine Psychosocial Care of Adult Childhood Cancer Survivors · St. Jude Children's Research Hospital
Eye & vision (7 active studies)
- An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease · Phase 2 · Dompé Farmaceutici S.p.A
- A Clinical Study Evaluating Licaminlimab for Dry Eye Disease · Phase 2, Phase 3 · Oculis
Vaccines (1 active study)
Common conditions studied in Memphis
- Sickle Cell Disease (18 active studies)
- Cancer (12 active studies)
- Acute Myeloid Leukemia (9 active studies)
- Neuroblastoma (8 active studies)
- Acute Lymphoblastic Leukemia (7 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Memphis
- St. Jude Children's Research Hospital
- National Cancer Institute (NCI)
- Children's Oncology Group
- SWOG Cancer Research Network
- University of Tennessee
Frequently asked questions
How many paid clinical trials are currently recruiting in Memphis?
There are approximately 455 recruiting clinical trials in Memphis, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Memphis pay participants?
Most recruiting trials in Memphis compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Memphis?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Memphis?
The most common conditions under active study in Memphis include Sickle Cell Disease (18), Cancer (12), Acute Myeloid Leukemia (9), Neuroblastoma (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Memphis?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Memphis on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Memphis?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Memphis?
Recruiting research sites in Memphis include St. Jude Children's Research Hospital, Baptist Memorial Hospital and Cancer Center-Memphis, Saint Jude Children's Research Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Memphis right now?
The largest active categories in Memphis are Cancer & tumors (170), Cardiovascular (25), Neurology & pain (22). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.